{
  "zip": "L6H 0G5",
  "sector": "Healthcare",
  "longBusinessSummary": "Cardiol Therapeutics Inc. focuses on the production of pharmaceutical cannabidiol (CBD) products. The company is also developing various therapies for heart diseases, including acute myocarditis and other causes of heart failure. Its lead product is CardiolRx, a pharmaceutically-produced CBD formulation. In addition, it is developing nanotechnology to deliver pharmaceutical CBD and other anti-inflammatory drugs directly to sites of inflammation in the heart that are associated with heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is based in Oakville, Canada.",
  "city": "Oakville",
  "phone": "289 910 0850",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.cardiolrx.com",
  "maxAge": 1,
  "address1": "2265 Upper Middle Road East",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "Suite 602",
  "previousClose": 2.65,
  "regularMarketOpen": 2.79,
  "twoHundredDayAverage": 2.3343751,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 2.79,
  "navPrice": null,
  "averageDailyVolume10Day": 174750,
  "totalAssets": null,
  "regularMarketPreviousClose": 2.65,
  "fiftyDayAverage": 2.3343751,
  "trailingAnnualDividendRate": null,
  "open": 2.79,
  "averageVolume10days": 174750,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.050616,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 2.643,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 120567,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 88772016,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 174750,
  "priceToSalesTrailing12Months": null,
  "dayLow": 2.643,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 120567,
  "fiftyTwoWeekHigh": 2.88,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 2.04,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 2.79,
  "exchange": "PNK",
  "shortName": "CARDIOL THERAPEUTICS INC",
  "longName": "Cardiol Therapeutics Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CRTPF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_424954803",
  "uuid": "6a0dee72-1bf0-3d92-9b94-cd2920fbf60a",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 32812200,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.03122,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.11507,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 29018019,
  "enterpriseValue": 87069168,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 2.79,
  "logo_url": "https://logo.clearbit.com/cardiolrx.com"
}